Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

How Is Inflammaging Measured?

Inflammaging is measured through circulating inflammatory mediators, immune-cell phenotyping, and composite inflammatory indices, with muscle, vascular, and metabolic models supplying most of the current evidence.

peptides-pro Editorial

Inflammaging is the term used for chronic, low-grade, systemic inflammation that rises with age in the absence of an overt infection. It is not a single analyte and it has no agreed diagnostic threshold; it is a conceptual construct assembled from several measurable domains. In the research literature those domains are: circulating cytokines and acute-phase proteins (interleukin-6, tumour necrosis factor-alpha, C-reactive protein), immune-cell composition and phenotype, oxidative and antioxidant capacity markers, and composite scores that combine several of these into one index. The construct is described as a shared regulator of calcium trafficking, inflammation resolution, vascular integrity, and inflammaging within a proposed "Heart-Brain-Bone" axis, which the authors explicitly frame as an integrative conceptual framework rather than a validated physiological entity with agreed diagnostic criteria [1].

Measurement work in this area centres on cytokine and myokine signalling — the interleukin-6, insulin-like growth factor-1, cathepsin B, irisin/FNDC5, brain-derived neurotrophic factor, and growth differentiation factor-15 families — together with the senescence-associated secretory phenotype and the mitochondrial dysfunction pathways that feed it [2][3].

Research Studies

Inflammaging and the sarcopenic muscle phenotype

Sarcopenia is a progressive age-related skeletal muscle disorder defined by loss of muscle mass, strength, and physical performance, and it is associated with frailty, disability, and increased mortality. A review of biomarkers and early mechanisms reported that sarcopenia arises from interacting processes including mitochondrial dysfunction, chronic low-grade inflammation, cellular senescence, neuromuscular junction degeneration, and anabolic resistance [3]. In that framing, inflammaging is not measured as a single value but inferred from a panel spanning inflammatory mediators, mitochondrial readouts, and senescence markers.

Circulating interleukins and myokines in elderly glucose-metabolism cohorts

A registered study characterises glucose metabolism and inflammaging in adults aged 70 years and older, correlating patterns of insulin secretion and sensitivity with muscle quality and quantity. The investigators compare healthy, sarcopenic, diabetic, and diabetic-sarcopenic groups and expect to identify an oxidative/inflammatory signature — circulating interleukins and myokines plus plasma antioxidant capacity — specific to the sarcopenic phenotype and related to muscle insulin resistance [6]. This is the clearest example in the current evidence of a multi-analyte signature being used as the measurement instrument rather than a single cytokine.

Myokines as mediators linking muscle loss to cognitive decline

A narrative review synthesised mechanistic and translational evidence on how skeletal muscle communicates with the ageing brain via myokines and exerkines, naming irisin/FNDC5, brain-derived neurotrophic factor, interleukin-6, insulin-like growth factor-1, cathepsin B, and growth differentiation factor-15, and describing how progressive sarcopenia disrupts that signalling in a way that accelerates cognitive impairment [2]. In this model, the same circulating mediators used to index inflammaging double as the readout of muscle-brain communication.

Lipid-soluble nutrients and the Heart-Brain-Bone framework

Mechanistic data indicate that cardiovascular disease, neurocognitive decline, and osteoporotic bone loss are coupled through shared regulators of calcium trafficking, inflammation resolution, vascular integrity, and inflammaging, which is the basis for the proposed Heart-Brain-Bone axis. The authors state that this should be understood as an integrative conceptual framework organising evidence from three separate studies, not as a validated physiological entity with agreed diagnostic criteria or demonstrated modifiability [1].

Nutritional regimens and inflammaging in cardiovascular risk

A registered study notes prior evidence linking fruit and vegetable consumption to reduced cardiac risk, potentially mediated through blood pressure, platelet function, and vascular reactivity, and through antioxidant and anti-inflammatory effects of certain vitamins and polyphenols on immune-cell function. It also cites prior work on omega-3 fatty acids and cardiovascular and lipid effects, and on their involvement in the inflammatory response [5]. Inflammaging endpoints in this design sit alongside conventional cardiovascular and lipid measures.

Surgical stress as an acute inflammatory comparator

Coronary artery bypass grafting, performed in approximately 400,000 patients per year in the United States, invokes a large surgical stress response in which systemic epinephrine rises 33-fold and norepinephrine 3-fold. Local tissue injury produces sterile inflammation with release of damage-associated molecular patterns, which activate neutrophils and trigger a cascade of cytokines, complement, and coagulation changes; nociceptor activation drives a neurometabolic response involving the sympathetic nervous system and the hypothalamus-pituitary axis [4]. This study provides an acute, high-amplitude inflammatory context against which age-related low-grade inflammation can be contrasted.

Vascular ageing and aneurysm wall degeneration

Ageing is a major risk factor for the formation, growth, and rupture of intracranial aneurysms, and evidence beyond chronological ageing points to vascular ageing driven by cellular senescence, chronic inflammation, and haemodynamic stress [8]. Inflammaging is therefore assessed here through tissue-level vascular pathology rather than blood analytes alone.

Skin ageing signatures and next-generation diagnostics

Skin ageing is described as multifactorial and dynamically regulated, shaped by intrinsic genetic programming and extrinsic environmental stressors, with chronological ageing dominated by molecular signatures including telomere attrition, mitochondrial dysfunction, and epigenetic drift [9]. These signatures are measured in tissue and provide a compartment-specific route to inflammaging-adjacent readouts.

Ovarian ageing and the systemic inflammatory axis

Ovarian ageing may contribute to systemic ageing through an ovarian-systemic axis. Intrinsic ovarian defects including genomic instability, epigenetic shifts, and mitochondrial and proteostasis damage may trigger senescence-associated secretory phenotype-related inflammaging and fibrosis [10]. This positions SASP output as a measurable bridge between a local ageing organ and systemic inflammatory tone.

DNA damage response overactivation as an upstream node

Aging is multi-causal, but its molecular hallmarks may converge on a small number of upstream integrating nodes. One hypothesis proposes that chronic, largely mutation-independent overactivation of the DNA damage response is such a node, dysregulating intact tumour-suppressor and guardian networks [7]. This is a mechanistic hypothesis rather than a measurement protocol, and it is included here only as context for why inflammaging markers are treated as downstream readouts.

Comparison of measurement domains

DomainExample readoutsModel or population in the evidence
Circulating mediatorsInterleukins, myokines, plasma antioxidant capacityAdults aged 70+ across healthy, sarcopenic, diabetic, and diabetic-sarcopenic groups [6]
Myokine/exerkine panelIrisin/FNDC5, BDNF, IL-6, IGF-1, cathepsin B, GDF-15Narrative review of muscle-brain axis evidence in older adults [2]
Composite mechanistic panelMitochondrial dysfunction, senescence, neuromuscular junction degeneration, anabolic resistanceReview of sarcopenia biomarkers [3]
Acute inflammatory comparatorEpinephrine, norepinephrine, DAMPs, cytokines, complementCABG surgical stress study [4]
Tissue-level vascular pathologyCellular senescence, chronic inflammation, haemodynamic stressIntracranial aneurysm vascular ageing review [8]

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research use only. We do not provide dosing information or medical guidance of any kind. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp